Alzheimer's disease and depression in the elderly: A trajectory linking gut microbiota and serotonin signaling

被引:8
作者
Cutuli, Debora [1 ,2 ]
Giacovazzo, Giacomo [2 ]
Decandia, Davide [1 ,2 ]
Coccurello, Roberto [2 ,3 ]
机构
[1] Univ Roma La Sapienza, Dept Psychol, Rome, Italy
[2] Santa Lucia Fdn IRCCS, European Ctr Brain Res, Rome, Italy
[3] Natl Council Res CNR, Inst Complex Syst ISC, Rome, Italy
来源
FRONTIERS IN PSYCHIATRY | 2022年 / 13卷
关键词
dementia; Alzheimer's disease; aging; neuropsychiatric symptoms; depression; gut microbiota; tryptophan; serotonin; MILD COGNITIVE IMPAIRMENT; BLOOD-BRAIN-BARRIER; NEUROPSYCHIATRIC SYMPTOMS; TRYPTOPHAN-METABOLISM; INTESTINAL EPITHELIUM; IMMUNE ACTIVATION; DIET; RECEPTORS; BACTERIA; MICE;
D O I
10.3389/fpsyt.2022.1010169
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The occurrence of neuropsychiatric symptoms in the elderly is viewed as an early sign of subsequent cognitive deterioration and conversion from mild cognitive impairment to Alzheimer's disease. The prognosis in terms of both the severity and progression of clinical dementia is generally aggravated by the comorbidity of neuropsychiatric symptoms and decline in cognitive function. Undeniably, aging and in particular unhealthy aging, is a silent "engine of neuropathology" over which multiple changes take place, including drastic alterations of the gut microbial ecosystem. This narrative review evaluates the role of gut microbiota changes as a possible unifying concept through which the comorbidity of neuropsychiatric symptoms and Alzheimer's disease can be considered. However, since the heterogeneity of neuropsychiatric symptoms, it is improbable to describe the same type of alterations in the bacteria population observed in patients with Alzheimer's disease, as well as it is improbable that the variety of drugs used to treat neuropsychiatric symptoms might produce changes in gut bacterial diversity similar to that observed in the pathophysiology of Alzheimer's disease. Depression seems to be another very intriguing exception, as it is one of the most frequent neuropsychiatric symptoms in dementia and a mood disorder frequently associated with brain aging. Antidepressants (i.e., serotonin reuptake inhibitors) or tryptophan dietary supplementation have been shown to reduce Amyloid beta-loading, reinstate microbial diversity and reduce the abundance of bacterial taxa dominant in depression and Alzheimer's disease. This review briefly examines this trajectory by discussing the dysfunction of gut microbiota composition, selected bacterial taxa, and alteration of tryptophan and serotonin metabolism/neurotransmission as overlapping in-common mechanisms involved with depression, Alzheimer's disease, and unhealthy aging.
引用
收藏
页数:11
相关论文
共 140 条
  • [1] Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function
    Abreu, Maria T.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2010, 10 (02) : 131 - 143
  • [2] Role of indoleamine 2,3-dioxygenase in pathology of the gastrointestinal tract
    Acovic, Aleksandar
    Gazdic, Marina
    Jovicic, Nemanja
    Harrell, C. Randall
    Fellabaum, Crissy
    Arsenijevic, Nebojsa
    Volarevic, Vladislav
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2018, 11
  • [3] Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
    Agus, Allison
    Planchais, Julien
    Sokol, Harry
    [J]. CELL HOST & MICROBE, 2018, 23 (06) : 716 - 724
  • [4] Almulla AF., MEDRXIV, DOI [10.1101/2022.03.18.22272608, DOI 10.1101/2022.03.18.22272608]
  • [5] The Possibility of an Infectious Etiology of Alzheimer Disease
    Ashraf, Ghulam M.
    Tarasov, Vadim V.
    Makhmutova, Alfiya
    Chubarev, Vladimir N.
    Avila-Rodriguez, Marco
    Bachurin, Sergey O.
    Aliev, Gjumrakch
    [J]. MOLECULAR NEUROBIOLOGY, 2019, 56 (06) : 4479 - 4491
  • [6] The Ageing Brain: Molecular and Cellular Basis of Neurodegeneration
    Azam, Shofiul
    Haque, Md Ezazul
    Balakrishnan, Rengasamy
    Kim, In-Su
    Choi, Dong-Kug
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 09
  • [7] Accelerated brain aging in major depressive disorder and antidepressant treatment response: A CAN-BIND report
    Ballester, Pedro L.
    Suh, Jee Su
    Nogovitsyn, Nikita
    Hassel, Stefanie
    Strother, Stephen C.
    Arnott, Stephen R.
    Minuzzi, Luciano
    Sassi, Roberto B.
    Lam, Raymond W.
    Milev, Roumen
    Muller, Daniel J.
    Taylor, Valerie H.
    Kennedy, Sidney H.
    Frey, Benicio N.
    [J]. NEUROIMAGE-CLINICAL, 2021, 32
  • [8] The blood-brain barrier in neuroimmunology: Tales of separation and assimilation
    Banks, W. A.
    [J]. BRAIN BEHAVIOR AND IMMUNITY, 2015, 44 : 1 - 8
  • [9] Blood-brain barrier transport of cytokines: A mechanism for neuropathology
    Banks, WA
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (08) : 973 - 984
  • [10] Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit
    Banks, William A.
    Gray, Alicia M.
    Erickson, Michelle A.
    Salameh, Therese S.
    Damodarasamy, Mamatha
    Sheibani, Nader
    Meabon, James S.
    Wing, Emily E.
    Morofuji, Yoichi
    Cook, David G.
    Reed, May J.
    [J]. JOURNAL OF NEUROINFLAMMATION, 2015, 12